Estrogen Receptors and Estrogen-Induced Uterine Vasodilation in Pregnancy
Open Access
- 18 June 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (12) , 4349
Abstract
Normal pregnancy is associated with dramatic increases in uterine blood flow to facilitate the bidirectional maternal–fetal exchanges of respiratory gases and to provide sole nutrient support for fetal growth and survival. The mechanism(s) underlying pregnancy-associated uterine vasodilation remain incompletely understood, but this is associated with elevated estrogens, which stimulate specific estrogen receptor (ER)-dependent vasodilator production in the uterine artery (UA). The classical ERs (ERα and ERβ) and the plasma-bound G protein-coupled ER (GPR30/GPER) are expressed in UA endothelial cells and smooth muscle cells, mediating the vasodilatory effects of estrogens through genomic and/or nongenomic pathways that are likely epigenetically modified. The activation of these three ERs by estrogens enhances the endothelial production of nitric oxide (NO), which has been shown to play a key role in uterine vasodilation during pregnancy. However, the local blockade of NO biosynthesis only partially attenuates estrogen-induced and pregnancy-associated uterine vasodilation, suggesting that mechanisms other than NO exist to mediate uterine vasodilation. In this review, we summarize the literature on the role of NO in ER-mediated mechanisms controlling estrogen-induced and pregnancy-associated uterine vasodilation and our recent work on a “new” UA vasodilator hydrogen sulfide (H2S) that has dramatically changed our view of how estrogens regulate uterine vasodilation in pregnancy.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (HL70562, HL98746, HL117941)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD097498)
- American Heart Association (20POST35090000)
This publication has 436 references indexed in Scilit:
- Reduced Cystathionine γ-Lyase and Increased miR-21 Expression Are Associated with Increased Vascular Resistance in Growth-Restricted PregnanciesThe American Journal of Pathology, 2013
- Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivityThe Journal of Steroid Biochemistry and Molecular Biology, 2011
- Estrogen‐responsive nitroso‐proteome in uterine artery endothelial cells: Role of endothelial nitric oxide synthase and estrogen receptor‐βJournal of Cellular Physiology, 2011
- Redox regulation of guanylate cyclase and protein kinase G in vascular responses to hypoxiaRespiratory Physiology & Neurobiology, 2010
- Role of KATP and L-type Ca2+ channel activities in regulation of ovine uterine vascular contractility: effect of pregnancy and chronic hypoxiaAmerican Journal of Obstetrics and Gynecology, 2010
- Effect of Heme Oxygenase-1 Deficiency on Placental DevelopmentPlacenta, 2009
- Estrogen receptor‐alpha (ER‐α) suppresses expression of its variant ER‐α36FEBS Letters, 2009
- Estrogenic control of mitochondrial function and biogenesisJournal of Cellular Biochemistry, 2008
- Transcriptional regulation of endothelial nitric oxide synthase expression in uterine artery endothelial cells by c-Jun/AP-1Molecular and Cellular Endocrinology, 2007
- The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cellsHeart and Vessels, 2004